| Identification | Back Directory | [Name]
Alectinib Impurity | [CAS]
1256584-83-4 | [Synonyms]
Alectinib Impurity
Alectinib Impurity 11
9-Ethyl-6,11-dihydro-6,6-dimethyl-11-oxo-8-(4-oxo-1-piperidinyl)-5H-benzo[b]carbazole-3-carbonitrile
5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-11-oxo-8-(4-oxo-1-piperidinyl)- | [Molecular Formula]
C26H25N3O2 | [MDL Number]
MFCD31631182 | [MOL File]
1256584-83-4.mol | [Molecular Weight]
411.5 |
| Chemical Properties | Back Directory | [Boiling point ]
696.8±55.0 °C(Predicted) | [density ]
1.31±0.1 g/cm3(Predicted) | [solubility ]
Dichloromethane; Methanol | [form ]
Solid | [pka]
13.70±0.40(Predicted) | [color ]
Pale Yellow |
| Hazard Information | Back Directory | [Uses]
9-Ethyl-6,11-dihydro-6,6-dimethyl-11-oxo-8-(4-oxo-1-piperidinyl)-5H-benzo[b]carbazole-3-carbonitrile is an intermediate in synthesizing Alectinib M4 metabolite (A521150). It is the major active metabolite of Alectinib. Alectinib is an anaplastic lymphoma kinase (ALK) inhibitor and is used to treat non-?small-?cell lung cancer by blocking the activity of anaplastic lymphoma kinase (ALK). |
|
|